Abstract
Introduction: Results in a Tobacco Consulting Room in 2009. Material and Methods: Retrospective descriptive analysis of the results obtained from patients who were attended in a Tobacco Consulting Room from 1 January to 31 December 2009 and subsequent follow-up to complete a year. Results: 291 of 428 patients (51.2% male), mean age 46 years and mean cigarettes/day 27.5. Moderate-severe nicotine dependence (Fagerström 6.8) and high motivation (Richmond 8.11). Respiratory comorbidity: 12.1% COPD, 7.6% asthma, 11% OSAHS and 0.3% HOT; Cardiac: Ischemic Cardiopaty, 4.8% and Arrhytmia, 2.1%; CVRF: 30.9% dyslipidemia, 19.9% HT and 9.3% DM. 42.6% global psychiatric comorbidity, 37.5% depression and/or anxiety and 13.4% alcoholism. 22% without treatment, 44.6% NRT, 13.1% bupropion and 20.3% varenicline. Those who were treated pharmacologically, although non statistical significance, greater number of days of abstinence among who used varenicline than NRT or bupropion (59.3 vs. 46.7). 7.2% never got more than 24 hours abstinence. Overall of the 291 patients, treatment success (one year without smoking) in 31 (10.7%); Percentage rises to 24.8% if we don't consider those who didn't attend the second consultation. Conclusions: 1. 70.8% didn't start treatment (32% and 57%, first and second appointment respectively). 2. Moderate-severe nicotine dependence and high motivation. 3. Severe comorbidity, especially psychiatric, respiratory and CVRF. 4. Greater number of days of abstinence among who used varenicline than NRT or bupropion (59.3 vs. 46.7). 5. 7.2% never got more than 24 hours abstinence. 6. Overall treatment success 10.7%, amounting to 24.8% excluding those who don't attend the second consultation.
- © 2012 ERS